New IVF hormone strategy tested to boost pregnancy odds for women over 35
NCT ID NCT04719000
Summary
This study is testing whether adding a hormone called recombinant LH to the standard fertility medication (FSH) improves outcomes for women over 35 who had a lower-than-expected number of eggs retrieved in a previous IVF cycle. The goal is to see if this personalized approach leads to better egg quality and higher pregnancy rates. Participants will be randomly assigned to receive either the standard medication or the standard medication plus the added LH hormone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFERTILITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Universitario Quiron Dexeus
RECRUITINGBarcelona, 08028, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.